These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7670944)

  • 1. Plasma homocysteine levels in patients with deep venous thrombosis.
    Amundsen T; Ueland PM; Waage A
    Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1321-3. PubMed ID: 7670944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease.
    Fermo I; Vigano' D'Angelo S; Paroni R; Mazzola G; Calori G; D'Angelo A
    Ann Intern Med; 1995 Nov; 123(10):747-53. PubMed ID: 7574192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma homocysteine assay in the exploration of thrombosis in young subjects].
    Bienvenu T; Ankri A; Chadefaux B; Kamoun P
    Presse Med; 1991 Jun; 20(21):985-8. PubMed ID: 1829214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis.
    den Heijer M; Koster T; Blom HJ; Bos GM; Briet E; Reitsma PH; Vandenbroucke JP; Rosendaal FR
    N Engl J Med; 1996 Mar; 334(12):759-62. PubMed ID: 8592549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperhomocysteinemia: a risk factor for arterial and venous thrombotic disease.
    Cattaneo M
    Int J Clin Lab Res; 1997; 27(3):139-44. PubMed ID: 9352375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Homocysteine and venous thromboembolism].
    Monnerat C; Hayoz D
    Schweiz Med Wochenschr; 1997 Sep; 127(36):1489-96. PubMed ID: 9309844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperhomocysteinemia and deep-vein thrombosis. A case-control study.
    Simioni P; Prandoni P; Burlina A; Tormene D; Sardella C; Ferrari V; Benedetti L; Girolami A
    Thromb Haemost; 1996 Dec; 76(6):883-6. PubMed ID: 8972005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperhomocysteinaemia as a risk factor for deep-vein thrombosis.
    Unlü Y; Keleş S; Becit N; Koçoğullari CU; Koçak H; Bakan E
    Eur J Vasc Endovasc Surg; 2005 Sep; 30(3):315-8. PubMed ID: 15963742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homocysteine and venous thrombosis: outline of a vitamin intervention trial.
    Willems HP; den Heijer M; Bos GM
    Semin Thromb Hemost; 2000; 26(3):297-304. PubMed ID: 11011847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperhomocysteinemia as a risk factor for arterial and venous disease. A review of evidence and relevance.
    Boers GH
    Thromb Haemost; 1997 Jul; 78(1):520-2. PubMed ID: 9198207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications.
    Erzin Y; Uzun H; Celik AF; Aydin S; Dirican A; Uzunismail H
    J Clin Gastroenterol; 2008; 42(5):481-6. PubMed ID: 18344891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyperhomocysteinemia: a risk factor for arterial and venous thrombosis].
    Wuillemin WA; Solenthaler M
    Vasa; 1999 Aug; 28(3):151-5. PubMed ID: 10483317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of hyperhomocysteinemia in vascular disease: comparative study of thrombotic venous disease vis-à-vis occlusive arterial disease.
    Bhargava S; Parakh R; Manocha A; Ali A; Srivastava LM
    Vascular; 2007; 15(3):149-53. PubMed ID: 17573020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homocysteine in inflammatory bowel disease: a risk factor for thromboembolic complications?
    Oldenburg B; Fijnheer R; van der Griend R; vanBerge-Henegouwen GP; Koningsberger JC
    Am J Gastroenterol; 2000 Oct; 95(10):2825-30. PubMed ID: 11051355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma homocysteine cutoff values for venous thrombosis.
    Castañon MM; Lauricella AM; Kordich L; Quintana I
    Clin Chem Lab Med; 2007; 45(2):232-6. PubMed ID: 17311514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hyperhomocysteinemia: a new marker of vascular risk: affected vascular areas, its role in the pathogenesis of arteriosclerosis and thrombosis and treatment].
    Córdoba Porras A; Blanco Vaca F; González Sastre F
    Med Clin (Barc); 1997 Nov; 109(18):715-25. PubMed ID: 9499150
    [No Abstract]   [Full Text] [Related]  

  • 17. Hyperhomocysteinemia and venous thrombosis: a meta-analysis.
    den Heijer M; Rosendaal FR; Blom HJ; Gerrits WB; Bos GM
    Thromb Haemost; 1998 Dec; 80(6):874-7. PubMed ID: 9869152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined vitamin B6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia.
    van den Berg M; Franken DG; Boers GH; Blom HJ; Jakobs C; Stehouwer CD; Rauwerda JA
    J Vasc Surg; 1994 Dec; 20(6):933-40. PubMed ID: 7990188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low fasting methionine concentration as a novel risk factor for recurrent venous thrombosis.
    Keijzer MB; den Heijer M; Borm GF; Blom HJ; Vollset SE; Hermus AR; Ueland PM
    Thromb Haemost; 2006 Oct; 96(4):492-7. PubMed ID: 17003928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels of activated protein C in healthy subjects and patients with previous venous thromboembolism: relationships with plasma homocysteine levels.
    Cattaneo M; Franchi F; Zighetti ML; Martinelli I; Asti D; Mannucci PM
    Arterioscler Thromb Vasc Biol; 1998 Sep; 18(9):1371-5. PubMed ID: 9743224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.